A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent

scientific article

A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1600-0447.1971.TB03697.X
P698PubMed publication ID4947805

P2093author name stringF Baro
R Dom
R Van Lommel
P2860cites workThe optical isomers of 3H-labelled benzetimideQ48920268
Differential anticholinergic activity, metabolism and excretion of the optical isomers of 14C-benzetimide hydrochlorideQ49029243
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectextrapyramidal symptomsQ1385411
Parkinson's diseaseQ11085
P304page(s)399-410
P577publication date1971-01-01
P1433published inActa Psychiatrica ScandinavicaQ4033348
P1476titleA quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent
P478volume47

Reverse relations

cites work (P2860)
Q34699531A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia
Q44298137Fluspirilene, an injectable, and penfluridol, an oral long-acting, neuroleptic. A comparative double-blind trial in residual schizophrenia

Search more.